Shots: The Lucid-Penn agreement will evaluate Lucid’s EsoCheck esophageal cell collection device with Collect+Protect technology as a less invasive, more efficient, and cost-effective alternative to endoscopic biopsies to manage patients […]readmore
Tags : Evalaute